Didier Blondel

Didier Blondel has served as Abivax's Executive Vice President, Chief Financial Officer and Board Secretary since January 2017. From January 2012 to December 2016 he was Chief Financial Officer at Sanofi Pasteur MSD, a Lyon-based joint venture between Sanofi and Merck and a European leader in human vaccines. Over a prior 20-year period he held a wide range of senior finance positions at Sanofi, in commercial operations and then research and development, where he became global research and development Chief Financial Officer. He began his career as an auditor at PricewaterhouseCoopers. He holds a Master's degree in Business and Administration from the Commercial Institute of Nancy (ICN), a Master's degree in Finance and Accounting from Nancy II University, and a graduate diploma in finance and accounting.

You're subscribed.

Thanks for signing up.